Wistrand advises Heraeus Dental in the acquisition of Biomain
On March 1, the German company Heraeus Dental, which is part of the precious metals and technology group Heraeus, headquartered in Hanau, Germany, acquired all shares in Biomain AB, Helsingborg.
With this acquisition, Heraeus strengthens its position and presence on the Northern European Dental CAD/CAM market and extends its patent and product portfolio in digital implant prosthetics.
Biomain AB is the Scandinavian market leader in the field of customized CAD/CAM based implant borne prosthetics.
Wistrand’s team advising the buyers consisted of partner Erik Hygrell and senior associate Henrik Aurelius.
Further information >>.
Similar articles
Wistrand advises in connection with Geelmuyden Kiese’s strategic acquisition of Wikberg&Frisk
Wistrand has advised in connection with the Scandinavian communication full service agency Geelmuyden Kiese’s acquisition of the...
